Fig. 1From: Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective studyFlow chart of screened patients. NSCLC non-small cell lung cancer, TKIs tyrosine kinase inhibitors, EGFR epidermal growth factor receptorBack to article page